Understanding Delayed Presentation to Emergency Care in Pediatric Patients With Neutropenic Fever
- PMID: 36219679
- PMCID: PMC10067535
- DOI: 10.1097/MPH.0000000000002562
Understanding Delayed Presentation to Emergency Care in Pediatric Patients With Neutropenic Fever
Abstract
We investigated social and logistic factors eg, distance from the medical center, language barriers, other children to care for, number of caregivers, etc.) for families to delay seeking immediate emergency care for neutropenic fever in a retrospective cohort study of all pediatric hematology-oncology patients who presented for fever in the setting of neutropenia to our emergency department or clinic from 2015 to 2020. Patients with a history of at least 2 prior admissions for neutropenic fever waited more often for a second fever before presenting versus those without such history (odds ratio 5.00, 95% CI 1.26 to 19.84, P =0.04). No other significant associations were found.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Funding Disclosures/Conflicts of interest: Statistical support and the work of author MLW are provided through Southern California Clinical and Translational Science Institute through an educational grant from the Los Angeles County Medical Center Committee for Interns and Residents (CIR), as well as grants UL1TR001855 and UL1TR000130 from the National Center for Advancing Translational Science (NCATS) of the U.S. National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest.
References
-
- Castagnola E, Fontana V, Caviglia I, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45:1296–1304. - PubMed
-
- Rondinelli PIP, Ribeiro K de CB, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28:665–670. - PubMed
-
- Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;52:e56–93. - PubMed
-
- Oberoi S, Das A, Trehan A, et al. Can complications in febrile neutropenia be predicted? Report from a developing country. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2017;25:3523–3528. - PubMed
-
- Volpe D, Harrison S, Damian F, et al. Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department. Pediatrics. 2012;130:e201–210. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical